• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, November 16, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Exploratory Five-Gene Osteosarcoma Risk Signature Fails External Cohort Validation

by
November 11, 2026
in Cancer, Health
Reading Time: 2 mins read
0
Exploratory Five-Gene Osteosarcoma Risk Signature Fails External Cohort Validation

Exploratory Five-Gene Osteosarcoma Risk Signature Fails External Cohort Validation

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A computational screening study that developed a five-gene prognostic risk signature for osteosarcoma identified significant overall survival stratification within its primary discovery cohort but failed to reproduce those survival differences across three independent validation cohorts. The exploratory model was derived from publicly available transcriptomic, clinical, and somatic mutation data to evaluate potential prognostic associations in primary bone cancer.

Osteosarcoma predominantly affects adolescents and young adults and remains characterized by high mortality and recurrence rates. To investigate potential molecular indicators, the researchers collected candidate genes through mitophagy- and tumor metabolism-associated queries in GeneCards alongside relevant literature, subsequently matching them against an osteosarcoma expression matrix to establish an initial pool of 3,745 analyzable candidate genes.

The investigators then applied exploratory differential expression analysis to this candidate set, identifying 25 candidate genes that met screening thresholds. Within this subgroup, 15 genes exhibited upregulated expression and 10 genes exhibited downregulated expression. Weighted gene co-expression network analysis, or WGCNA, was subsequently utilized to narrow these 25 candidates down to 12 module genes for downstream prognostic modeling.

Survival modeling within the TARGET-OS discovery cohort, which incorporated least absolute shrinkage and selection operator regression, prioritized a final five-gene risk signature. This model comprised BBS4, CTNND2, EPHA3, MAPK10, and MYC. When applied to the TARGET-OS discovery cohort, the five-gene signature stratified overall survival to a statistically significant degree with p < 0.001.

However, the signature’s survival stratification did not hold when evaluated in external datasets. Analysis of three independent validation cohorts revealed no statistically significant separation in overall survival, with p = 0.35 in GSE16091, p = 0.19 in GSE21257, and p = 0.61 in GSE39055. Downstream computational evaluations also documented risk-group-specific correlations with computationally estimated immune-cell features, described cell-type-specific expression profiles via single-cell analysis, and detected differences in computationally predicted drug responses.

The authors emphasized that the five genes represent statistically prioritized candidate biomarkers rather than confirmed mechanistic drivers, noting that direct functional contributions to mitophagy or tumor metabolism in osteosarcoma were not established. Consequently, the computational immune correlations and predicted drug sensitivities serve as exploratory hypotheses for future laboratory work rather than clinical guidance or validated evidence of immune regulation, leaving the five-gene signature unconfirmed without independent functional and prognostic verification.

Subject of Research: Computational prognostic risk signature screening in osteosarcoma

Article Title: A computationally derived five-gene risk signature from broad mitophagy- and tumor metabolism-associated candidate screening in osteosarcoma

Article References: Li, Y., Zhou, J., Gao, X., Liu, X., Wei, Z., & Gong, Y. (2026). A computationally derived five-gene risk signature from broad mitophagy- and tumor metabolism-associated candidate screening in osteosarcoma. Discover Oncology. https://doi.org/10.1007/s12672-026-06263-8

Image Credits: AI Generated

DOI: 10.1007/s12672-026-06263-8

Keywords: osteosarcoma, BBS4, CTNND2, EPHA3, MAPK10, MYC, mitophagy, tumor metabolism, TARGET-OS, GSE16091, GSE21257, GSE39055, LASSO regression, WGCNA, prognostic risk signature, differential expression analysis, single-cell analysis

News Source: Nathaniel Bowman. (November 11, 2026). Exploratory Five-Gene Osteosarcoma Risk Signature Fails External Cohort Validation. Scienmag.

Tags: BBS4CTNND2differential expression analysisEPHA3GSE16091GSE21257GSE39055LASSO regressionMAPK10MitophagyMycOsteosarcomaprognostic risk signaturesingle-cell analysisTARGET-OStumor metabolismWGCNA
Share12Tweet7Share2ShareShareShare1

Related Posts

Autoantibody Profiling and Machine Learning Improves Early Esophageal Cancer Detection

Autoantibody Profiling and Machine Learning Improves Early Esophageal Cancer Detection

November 16, 2026
Large-Scale Genetic Study Links Cervical Spinal Cord Morphology to Systemic Health

Large-Scale Genetic Study Links Cervical Spinal Cord Morphology to Systemic Health

November 16, 2026

Study Finds Childhood Adversity Affects Prefrontal Cortex Rather Than Limbic Structures

November 16, 2026

CD40-Activated B Cells Boost Antitumor T-Cell Immunity Against Colorectal Cancer in Mice

November 16, 2026

POPULAR NEWS

  • Maintenance BCG Reduces Bladder Cancer Progression When Patients Overcome Treatment Barriers

    Maintenance BCG Reduces Bladder Cancer Progression When Patients Overcome Treatment Barriers

    29 shares
    Share 12 Tweet 7
  • High-Avidity BCMA CAR T-Cell Therapy Shows High Efficacy in AL Amyloidosis

    29 shares
    Share 12 Tweet 7
  • Zero Mass Limit in Karch-Randall Gravity Yields Decoupled Massive Vector Theory

    29 shares
    Share 12 Tweet 7
  • Kenyan Smallholder Farmers Classify Diverse Pasture Species for Sustainable Dairy Production

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Autoantibody Profiling and Machine Learning Improves Early Esophageal Cancer Detection

Large-Scale Genetic Study Links Cervical Spinal Cord Morphology to Systemic Health

Study Finds Childhood Adversity Affects Prefrontal Cortex Rather Than Limbic Structures

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 87 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.